Folgen
Michael MacManus
Michael MacManus
Professor University of Melbourne, Radiation Oncologist, Peter MacCallum Cancer Centre
Bestätigte E-Mail-Adresse bei petermac.org
Titel
Zitiert von
Zitiert von
Jahr
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non–small-cell …
MP Mac Manus, RJ Hicks, JP Matthews, A McKenzie, D Rischin, ...
Journal of Clinical Oncology 21 (7), 1285-1292, 2003
5282003
Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
MP Mac Manus, RT Hoppe
Journal of Clinical Oncology 14 (4), 1282-1290, 1996
5251996
Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007
M MacManus, U Nestle, KE Rosenzweig, I Carrio, C Messa, O Belohlavek, ...
Radiotherapy and oncology 91 (1), 85-94, 2009
4712009
Abscopal effects of radiation therapy: a clinical review for the radiobiologist
S Siva, MP MacManus, RF Martin, OA Martin
Cancer letters 356 (1), 82-90, 2015
4552015
High rate of detection of unsuspected distant metastases by PET in apparent Stage III non–small-cell lung cancer: implications for radical radiation therapy
MP Mac Manus, RJ Hicks, JP Matthews, A Hogg, AF McKenzie, A Wirth, ...
International Journal of Radiation Oncology* Biology* Physics 50 (2), 287-293, 2001
3712001
18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non–small cell lung cancer
RJ Hicks, V Kalff, MP MacManus, RE Ware, A Hogg, AF McKenzie, ...
Journal of Nuclear Medicine 42 (11), 1596-1604, 2001
3042001
Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non–small-cell lung cancer: a prospective study
V Kalff, RJ Hicks, M P MacManus, DS Binns, AF McKenzie, RE Ware, ...
Journal of clinical oncology 19 (1), 111, 2001
2972001
F‐18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high …
MP Mac Manus, RJ Hicks, DL Ball, V Kalff, JP Matthews, E Salminen, ...
Cancer 92 (4), 886-895, 2001
2792001
The utility of 18F-FDG PET for suspected recurrent non–small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification
RJ Hicks, V Kalff, MP MacManus, RE Ware, AF McKenzie, JP Matthews, ...
Journal of Nuclear Medicine 42 (11), 1605-1613, 2001
2442001
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review
S Siva, M MacManus, D Ball
Journal of Thoracic Oncology 5 (7), 1091-1099, 2010
2402010
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma
A Wirth, JF Seymour, RJ Hicks, R Ware, R Fisher, M Prince, ...
The American journal of medicine 112 (4), 262-268, 2002
2352002
Should extrapulmonary small cell cancer be managed like small cell lung cancer?
SM Brennan, DL Gregory, A Stillie, A Herschtal, M Mac Manus, DL Ball
Cancer: Interdisciplinary International Journal of the American Cancer …, 2010
2282010
A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer
T Leong, C Everitt, K Yuen, S Condron, A Hui, SYK Ngan, A Pitman, ...
Radiotherapy and oncology 78 (3), 254-261, 2006
2282006
Classification and evaluation strategies of auto‐segmentation approaches for PET: Report of AAPM task group No. 211
M Hatt, JA Lee, CR Schmidtlein, IE Naqa, C Caldwell, E De Bernardi, ...
Medical physics 44 (6), e1-e42, 2017
2072017
Early FDG-PET imaging after radical radiotherapy for non–small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound …
RJ Hicks, MP Mac Manus, JP Matthews, A Hogg, D Binns, D Rischin, ...
International Journal of Radiation Oncology* Biology* Physics 60 (2), 412-418, 2004
2062004
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure
MPM Manus, RJ Hicks, JP Matthews, A Wirth, D Rischin, DL Ball
Lung cancer 49 (1), 95-108, 2005
1942005
Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?
OA Martin, RL Anderson, K Narayan, MP MacManus
Nature reviews Clinical oncology 14 (1), 32-44, 2017
1762017
Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy
M Fay, A Tan, R Fisher, M Mac Manus, A Wirth, D Ball
International Journal of Radiation Oncology* Biology* Physics 61 (5), 1355-1363, 2005
1672005
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014
T Konert, W Vogel, MP MacManus, U Nestle, J Belderbos, V Grégoire, ...
Radiotherapy and Oncology 116 (1), 27-34, 2015
1562015
Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma
A Wirth, M Foo, JF Seymour, MP MacManus, RJ Hicks
International Journal of Radiation Oncology* Biology* Physics 71 (1), 213-219, 2008
1552008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20